» Articles » PMID: 31638322

Communicating Uncertainties when Disclosing Diagnostic Test Results for (Alzheimer's) Dementia in the Memory Clinic: The ABIDE Project

Abstract

Background: The development of novel diagnostics enables increasingly earlier diagnosis of Alzheimer's disease (AD). Timely diagnosis may benefit patients by reducing their uncertainty regarding the cause of symptoms, yet does not always provide patients with the desired certainty.

Objective: To examine, using both quantitative and qualitative methods, uncertainty communicated by memory clinic clinicians in post-diagnostic testing consultations with patients and their caregivers.

Methods: First, we identified all uncertainty expressions of 22 clinicians in audiotaped post-diagnostic testing consultations with 78 patients. Second, we statistically explored relationships between patient/clinician characteristics and uncertainty expressions. Third, the transcribed uncertainty expressions were qualitatively analysed, determining the topic to which they pertained, their source and initiator/elicitor (clinicians/patients/caregivers).

Results: Within 57/78 (73%) consultations, clinicians expressed in total 115 uncertainties, of which 37% elicited by the patient or caregiver. No apparent relationships were found between patient/clinician characteristics and whether or not, and how often clinicians expressed uncertainty. Uncertainty expressions pertained to ten different topics, most frequently patient's diagnosis and symptom progression. Expressed uncertainty was mostly related to the unpredictability of the future and limits to available knowledge.

Discussion And Conclusions: The majority of clinicians openly discussed the limits of scientific knowledge and diagnostic testing with patients and caregivers in the dementia context. Noticeably, clinicians did not discuss uncertainty in about one quarter of consultations. More evidence is needed on the beneficial and/or harmful effects on patients of discussing uncertainty with them. This knowledge can be used to support clinicians to optimally convey uncertainty and facilitate patients' uncertainty management.

Citing Articles

Facing the new diagnostic and treatment options of Alzheimer's disease: The necessity of informed consent.

Karneboge J, Haberstroh J, Geschke K, Perry J, Radenbach K, Jessen F Alzheimers Dement. 2024; 21(1):e14204.

PMID: 39740107 PMC: 11772727. DOI: 10.1002/alz.14204.


Informing Alzheimer's Biomarker Communication: Concerns and Understanding of Cognitively Unimpaired Adults During Amyloid Results Disclosure.

Ketchum F, Erickson C, Basche K, Chin N, Eveler M, Conway C J Prev Alzheimers Dis. 2024; 11(6):1572-1580.

PMID: 39559870 PMC: 11573811. DOI: 10.14283/jpad.2024.151.


Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia.

van der Veere P, Hoogland J, Visser L, Van Harten A, Rhodius-Meester H, Sikkes S Neurology. 2024; 103(3):e209605.

PMID: 38986053 PMC: 11238942. DOI: 10.1212/WNL.0000000000209605.


The expectations and experiences of patients regarding the diagnostic workup at a specialized memory clinic: An interview study.

Aspo M, Sundell M, Protsiv M, Wiggenraad F, Ryden M, Mangialasche F Health Expect. 2024; 27(2):e14021.

PMID: 38515262 PMC: 10958124. DOI: 10.1111/hex.14021.


Enhancing post-diagnostic care in Australian memory clinics: Health professionals' insights into current practices, barriers and facilitators, and desirable support.

Pavkovic S, Goldberg L, Farrow M, Alty J, Abela M, Naismith S Dementia (London). 2023; 23(1):109-131.

PMID: 38116661 PMC: 10797845. DOI: 10.1177/14713012231213419.


References
1.
Visser P, Verhey F, Knol D, Scheltens P, Wahlund L, Freund-Levi Y . Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol. 2009; 8(7):619-27. DOI: 10.1016/S1474-4422(09)70139-5. View

2.
Politi M, Clark M, Ombao H, Legare F . The impact of physicians' reactions to uncertainty on patients' decision satisfaction. J Eval Clin Pract. 2010; 17(4):575-8. PMC: 2978752. DOI: 10.1111/j.1365-2753.2010.01520.x. View

3.
Momen N, Hadfield P, Kuhn I, Smith E, Barclay S . Discussing an uncertain future: end-of-life care conversations in chronic obstructive pulmonary disease. A systematic literature review and narrative synthesis. Thorax. 2012; 67(9):777-80. DOI: 10.1136/thoraxjnl-2012-201835. View

4.
Kunneman M, Smets E, Bouwman F, Schoonenboom N, Zwan M, Pel-Littel R . Clinicians' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project. Alzheimers Dement (N Y). 2017; 3(3):305-313. PMC: 5651435. DOI: 10.1016/j.trci.2017.03.009. View

5.
Mattsson N, Brax D, Zetterberg H . To know or not to know: ethical issues related to early diagnosis of Alzheimer's disease. Int J Alzheimers Dis. 2010; 2010. PMC: 2925376. DOI: 10.4061/2010/841941. View